AbbVievsSanara MedTech

ABBV and SMTI stock compared: price, dividend, valuation and results, from SEC filings.

SMTI

Sanara MedTech Inc.

$32.80

Value $301M

+0.21%
SMTI's page

AbbVie (ABBV) has a market value of $507B and Sanara MedTech (SMTI) $301M. Over the last year, with dividends, ABBV moved +26.1% and SMTI +55.7%. Dividend yield: ABBV 2.41%, SMTI none.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    ABBV$507B

    SMTI$301M

    ABBV is 1,685 times SMTI

  • Revenue, 12 months

    ABBV$66.0B

    SMTI$112M

    ABBV is 590 times SMTI

  • Net income, 12 months

    ABBV$10.3B

    SMTI-$3.0M

  • Operating margin

    ABBV32.2%

    SMTI5.6%

    26.6 points apart

  • ROIC

    ABBV25.7%

    SMTI9.3%

    16.4 points apart

  • P/E

    ABBV49.2

    SMTI–

  • Dividend yield

    ABBV2.4%

    SMTI0.0%

    2.4 points apart

  • 5-year return

    ABBV+192.0%

    SMTI-1.8%

    193.8 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

ABBV+192.0%

SMTI-1.8%

10020030020222023202420252026
Returns by period
PeriodABBVWith dividendsSMTIWith dividends
1 year since November 17, 2025+26.1%Price +22.5%+55.7%Price +55.7%
3 years since November 17, 2023+129.1%+31.8% a yearPrice +107.2%-0.9%-0.3% a yearPrice -0.9%
5 years since November 17, 2021+192.0%+23.9% a yearPrice +144.2%-1.8%-0.4% a yearPrice -1.8%
10 years since November 18, 2016+612.0%+21.7% a yearPrice +373.6%+556.0%+20.7% a yearPrice +556.0%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

ABBVAbbVieSMTISanara MedTech

Valuation

ABBVSMTI
Valuation
Price$286.61$32.80
Market value$507B$301M
Enterprise value (EV)$577B–
P/E49.2–
P/E, 5-year median57.0–
P/B–39.2
EV/EBIT27.2–
Free cash flow yield3.7%2.4%

Results and growth

ABBVSMTI
Results and growth
Revenue, 12 months$66.0B$112M
Net income, 12 months$10.3B-$3.0M
Free cash flow, 12 months$18.9B$7.3M
Earnings per share, 12 months$5.81-$3.72
Revenue growth, year on year8.6%19.0%
Revenue growth a year, past+5.9%over 5 years+45.9%over 5 years
EPS growth a year, past-2.8%over 5 years–

Margins and returns on capital

ABBVSMTI
Margins and returns on capital
Gross margin73.7%93.0%
Operating margin32.2%5.6%
Net margin15.7%-2.7%
ROIC25.7%9.3%
ROE–-43.4%

Balance sheet

ABBVSMTI
Balance sheet
Cash$10.8B$17M
Total debt$80.9B–
Net debt / EBITDA3.2–
Interest cover7.1×0.9×

Dividends and buybacks

ABBVSMTI
Dividends and buybacks
Dividend yield2.4%–
Dividend per share, 12 months$6.92–
Dividend growth a year, past+6.6%over 5 years–
Buyback yield0.2%–
Shareholder yield2.6%–

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: ABBV or SMTI

Didn't find what you were looking for?

Ask us
Which is bigger, AbbVie or Sanara MedTech?

By market value, AbbVie ($507B) is about 1,685.5 times Sanara MedTech ($301M), at today's prices.

How did ABBV and SMTI stock do over the last 10 years?

Since November 18, 2016, ABBV's price moved +373.6% and SMTI's +556.0%. With dividends: ABBV +612.0% (+21.7% a year), SMTI +556.0% (+20.7% a year). Past returns do not predict future ones.

Which pays the higher dividend, ABBV or SMTI?

The dividend yield at today's price is 2.41% for AbbVie and none for Sanara MedTech. Over the last twelve months they paid $6.92 and – per share.

Which has the higher profit margins, AbbVie or Sanara MedTech?

Over the last twelve months, the net margin was 15.7% for AbbVie and -2.7% for Sanara MedTech, and the operating margin 32.2% and 5.6%. Revenue was $66.0B and $112M.

Which is the better investment, AbbVie or Sanara MedTech?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.